Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum - Poll - MDSpire

Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum

  • By

  • Andrea Mastrangelo

  • Angela Mammana

  • Sara Hall

  • Erik Stomrud

  • Corrado Zenesini

  • Marcello Rossi

  • Shorena Janelidze

  • Alice Ticca

  • Sebastian Palmqvist

  • Franco Magliocchetti

  • Simone Baiardi

  • Niklas Mattsson-Carlgren

  • Oskar Hansson

  • Piero Parchi

  • December 17, 2024

  • 0 min

Share

Original Source(s)

Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum

  • by Andrea Mastrangelo, Angela Mammana, Sara Hall, Erik Stomrud, Corrado Zenesini, Marcello Rossi, Shorena Janelidze, Alice Ticca, Sebastian Palmqvist, Franco Magliocchetti, Simone Baiardi, Niklas Mattsson-Carlgren, Oskar Hansson, Piero Parchi

  • December 17, 2024

Related Content

The Relationship Between Personality Traits and Alzheimer's Disease: A Narrative Review

Early neural shift detection using functional magnetic resonance imaging: a pilot study with Parkinson’s disease patients undergoing istradefylline and hybrid assistive limb interventions

Study on the effects and mechanisms of rhythmic auditory stimulation on freezing of gait in Parkinson’s disease: investigation based on functional near-infrared spectroscopy (fNIRS) technology